LABRHA participated in the last OARSI Congress which took place from the 31st of March to the 3rd of April 2016 in Amsterdam.
The company presented the results of the double-blind, controlled, multicenter, randomized trial conducted on 226 patients and comparing the efficacy and tolerance of HAppyVisc® vs. Euflexxa®.
The related abstract has been published in the volume 24, supplement 1 of the journal Osteoarthritis and Cartilage in April 2016:
Safety and efficacy of intra articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis. Results of a double-blind, controlled, multicenter, randomized trial. T. Conrozier, N. Afif, R. Lecurieux, A. Walliser, X. Chevalier. Osteoarthritis and Cartilage 04/2016; 24:S528. DOI: http://dx.doi.org/10.1016/j.joca.2016.01.966
Another abstract has been accepted and published in the same journal:
Obesity and severity of joint space narrowing are associated with a lower rate of success of viscosupplementation in patients with knee osteoarthritis. Post hoc analysis of a double blind, controlled, multicentre, randomized trial. F. Eymard, X. Chevalier, T. Conrozier. Osteoarthritis and Cartilage 04/2016; 24:S528. DOI:10.1016/j.joca.2016.01.965